UB Paderborn / Katalog / Suche / Details

Ergebnis 15 von 18768

Science (American Association for the Advancement of Science), 2017-04, Vol.356 (6336), p.397-397

2017

Autor(en) / Beteiligte

Titel

Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15

Ist Teil von

Science (American Association for the Advancement of Science), 2017-04, Vol.356 (6336), p.397-397

Ort / Verlag

United States: American Association for the Advancement of Science

Erscheinungsjahr

2017

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

Indisulam is an aryl sulfonamide drug with selective anticancer activity. Its mechanism of action and the basis for its selectivity have so far been unknown. Here we show that indisulam promotes the recruitment of RBM39 (RNA binding motif protein 39) to the CUL4-DCAF15 E3 ubiquitin ligase, leading to RBM39 polyubiquitination and proteasomal degradation. Mutations in RBM39 that prevent its recruitment to CUL4-DCAF15 increase RBM39 stability and confer resistance to indisulam's cytotoxicity. RBM39 associates with precursor messenger RNA (pre-mRNA) splicing factors, and inactivation of RBM39 by indisulam causes aberrant pre-mRNA splicing. Many cancer cell lines derived from hematopoietic and lymphoid lineages are sensitive to indisulam, and their sensitivity correlates with DCAF15 expression levels. Two other clinically tested sulfonamides, tasisulam and chloroquinoxaline sulfonamide, share the same mechanism of action as indisulam. We propose that DCAF15 expression may be a useful biomarker to guide clinical trials of this class of drugs, which we refer to as SPLAMs (splicing inhibitor sulfonamides).

Sprache: Englisch
Identifikatoren: ISSN: 0036-8075
eISSN: 1095-9203
DOI: 10.1126/science.aal3755
Titel-ID: cdi_proquest_miscellaneous_1904250407

Format: –
Schlagworte: Amino Acid Substitution, Amino acids, Animals, Anticancer properties, Antineoplastic Agents - adverse effects, Antineoplastic Agents - pharmacology, Antineoplastic Agents - therapeutic use, Antitumor activity, Antitumor agents, Aromatic compounds, Binding, Biomarkers, Biomarkers, Pharmacological - metabolism, Cancer, Cell Line, Tumor, Clinical trials, Copy number, Cytotoxicity, Degradation, Drug Resistance, Neoplasm - genetics, Drugs, Exon skipping, Gene expression, Gene sequencing, Genomes, Gluing, Hemopoiesis, Humans, Immunomodulation, Inactivation, Inhibitors, Leukemia, Lymphoma, Medical research, Mice, Mice, Knockout, Molecular Targeted Therapy, Mutation, Neoplasms - drug therapy, Nuclear Proteins - genetics, Nuclear Proteins - metabolism, Patients, Precursors, Proteasome Endopeptidase Complex - metabolism, Proteasomes, Proteins, Proteolysis, Receptors, Recruitment, RESEARCH ARTICLE SUMMARY, Ribonucleic acid, Ribonucleic acids, RNA, RNA Splicing - drug effects, RNA-binding protein, RNA-Binding Proteins - genetics, RNA-Binding Proteins - metabolism, Selectivity, Sensitivity, Solid tumors, Splicing, Splicing factors, Sulfonamides, Sulfonamides - adverse effects, Sulfonamides - pharmacology, Sulfonamides - therapeutic use, Toxicity, Tumor cell lines, Tumors, Ubiquitin-protein ligase, Ubiquitin-Protein Ligase Complexes - metabolism, Ubiquitination, Xenograft Model Antitumor Assays, Xenografts, Xenotransplantation

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX